Back to
Resona Asset Management Co., Ltd.
ARWR
Showing 5 of 7 quarters
Position history for
Resona Asset Management Co., Ltd.'s holdings in Arrowhead Pharmaceuticals, Inc.
No. Resona Asset Management exited its ARWR (Arrowhead Pharmaceuticals) position in Q3 2025. Its Q2 2025 13F listed 11,218 shares worth $180,385. Resona Asset Management already held ARWR in its Q1 2024 13F, the earliest on record, and held it in 6 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$96,696
Total Shares Change
-4,967
Quarter-by-Quarter History